Mengqing Xie

Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia

Jingnan Sun, Ruiping Hu, Mengyuan Han et al. · International Journal of Biological Sciences · 2023 · 32 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +19

Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy

Xin Yu, Jiaqi Li, Lingyun Ye et al. · Translational Lung Cancer Research · 2021 · 29 citations · Full text

Influence of Exosomes on Astrocytes in the Pre-Metastatic Niche of Lung Cancer Brain Metastases

Lingyun Ye, Yinfei Wu, Juan Zhou et al. · Biological Procedures Online · 2023 · 20 citations · Full text

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study

Xiangling Chu, Huiping Qiang, Mengqing Xie et al. · Cancer Immunology Immunotherapy · 2021 · 18 citations · Full text

Medicine, Immune Checkpoint Inhibitors, Immunology +9

Low baseline plasma <scp>PCSK9</scp> level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non‐small cell lung cancer

Mengqing Xie, Xin Yu, Xiangling Chu et al. · Thoracic Cancer · 2021 · 18 citations · Full text